Projects

Costing and Outcomes of Pediatric CKD: A multi-centre prospective study from low/ low middle income countries

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2021 - 2022

Project Lead

Dr Priya Pais

Authors

Dr. Priya Pais

Project Status

completed

Project Type

International Society of Nephrology, Clinical Research Program grant